MPR Weekly Dose Podcast #153

Two diabetes drugs permanently discontinued; Consistent reduction in schizophrenia symptoms found with an investigational Tx; Positive results for investigational social anxiety disorder therapy; High-concentration Humira biosimilar approved; Sleep apnea treatment expanded for pediatrics with Down syndrome.